{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,19]],"date-time":"2025-10-19T18:26:36Z","timestamp":1760898396663},"reference-count":36,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2017,7,13]],"date-time":"2017-07-13T00:00:00Z","timestamp":1499904000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Virchows Arch"],"published-print":{"date-parts":[[2017,11]]},"DOI":"10.1007\/s00428-017-2196-x","type":"journal-article","created":{"date-parts":[[2017,7,13]],"date-time":"2017-07-13T05:15:21Z","timestamp":1499922921000},"page":"619-629","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":17,"title":["Histological heterogeneity in primary and metastatic classic combined hepatocellular-cholangiocarcinoma: a case series"],"prefix":"10.1007","volume":"471","author":[{"given":"Claudio","family":"De Vito","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Debashis","family":"Sarker","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paul","family":"Ross","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nigel","family":"Heaton","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alberto","family":"Quaglia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2017,7,13]]},"reference":[{"key":"2196_CR1","doi-asserted-by":"publisher","first-page":"255","DOI":"10.2217\/hep.15.8","volume":"2","author":"EM Brunt","year":"2015","unstructured":"Brunt EM, Paradis V, Sempoux C, Theise ND (2015) Biphenotypic (hepatobiliary) primary liver carcinomas: the work in progress. Hepatic Oncol 2:255\u2013273. doi:\n10.2217\/hep.15.8","journal-title":"Hepatic Oncol"},{"key":"2196_CR2","first-page":"647","volume":"25","author":"RA Allen","year":"1949","unstructured":"Allen RA, Lisa JR (1949) Combined liver cell and bile duct carcinoma. Am J Pathol 25:647\u2013655","journal-title":"Am J Pathol"},{"key":"2196_CR3","unstructured":"Theise ND, Nakashima O, Park YN, Nakanuma Y (2010) Combined hepatocellular-cholangiocarcinoma. WHO Classification of digestive tumors"},{"key":"2196_CR4","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1007\/s11605-015-3045-3","volume":"20","author":"Y-I Yoon","year":"2016","unstructured":"Yoon Y-I, Hwang S, Lee Y-J, Kim K-H, Ahn C-S, Moon D-B, Ha T-Y, Song G-W, Jung D-H, Lee J-W, Hong S-M, Yu ES, Lee S-G (2016) Postresection outcomes of combined hepatocellular carcinoma-cholangiocarcinoma, hepatocellular carcinoma and intrahepatic cholangiocarcinoma. J Gastrointest Surg 20:411\u2013420. doi:\n10.1007\/s11605-015-3045-3","journal-title":"J Gastrointest Surg"},{"key":"2196_CR5","doi-asserted-by":"publisher","first-page":"2869","DOI":"10.1245\/s10434-012-2328-0","volume":"19","author":"X Yin","year":"2012","unstructured":"Yin X, Zhang B-H, Qiu S-J, Ren Z-G, Zhou J, Chen X-H, Zhou Y, Fan J (2012) Combined hepatocellular carcinoma and cholangiocarcinoma: clinical features, treatment modalities, and prognosis. Ann Surg Oncol 19:2869\u20132876. doi:\n10.1245\/s10434-012-2328-0","journal-title":"Ann Surg Oncol"},{"key":"2196_CR6","doi-asserted-by":"publisher","unstructured":"Fowler KJ, Sheybani A, Parker RA, Doherty S, M Brunt E, Chapman WC, Menias CO (2013) Combined hepatocellular and cholangiocarcinoma (biphenotypic) tumors: imaging features and diagnostic accuracy of contrast-enhanced CT and MRI. AJR Am J Roentgenol 201:332\u2013339. doi: \n10.2214\/AJR.12.9488","DOI":"10.2214\/AJR.12.9488"},{"key":"2196_CR7","doi-asserted-by":"publisher","first-page":"1271","DOI":"10.1111\/j.1742-1241.2007.01694.x","volume":"62","author":"WT Kassahun","year":"2008","unstructured":"Kassahun WT, Hauss J (2008) Management of combined hepatocellular and cholangiocarcinoma. Int J Clin Pract 62:1271\u20131278. doi:\n10.1111\/j.1742-1241.2007.01694.x","journal-title":"Int J Clin Pract"},{"key":"2196_CR8","doi-asserted-by":"publisher","first-page":"952","DOI":"10.1002\/lt.23897","volume":"20","author":"M Garancini","year":"2014","unstructured":"Garancini M, Goffredo P, Pagni F, Romano F, Roman S, Sosa JA, Giardini V (2014) Combined hepatocellular-cholangiocarcinoma: a population-level analysis of an uncommon primary liver tumor. Liver Transpl 20:952\u2013959. doi:\n10.1002\/lt.23897","journal-title":"Liver Transpl"},{"key":"2196_CR9","doi-asserted-by":"publisher","first-page":"944","DOI":"10.1097\/SLA.0000000000000494","volume":"259","author":"G Sapisochin","year":"2014","unstructured":"Sapisochin G, de Lope CR, Gastaca M, de Urbina JO, L\u00f3pez-Andujar R, Palacios F, Ramos E, Fabregat J, Castroagud\u00edn JF, Varo E, Pons JA, Parrilla P, Gonz\u00e1lez-Di\u00e9guez ML, Rodriguez M, Otero A, Vazquez MA, Zozaya G, Herrero JI, Antolin GS, Perez B, Ciria R, Rufian S, Fundora Y, Ferron JA, Guiberteau A, Blanco G, Varona MA, Barrera MA, Suarez MA, Santoyo J, Bruix J, Charco R (2014) Intrahepatic cholangiocarcinoma or mixed hepatocellular-cholangiocarcinoma in patients undergoing liver transplantation: a Spanish matched cohort multicenter study. Ann Surg 259:944\u2013952. doi:\n10.1097\/SLA.0000000000000494","journal-title":"Ann Surg"},{"key":"2196_CR10","doi-asserted-by":"publisher","first-page":"943","DOI":"10.1002\/lt.22314","volume":"17","author":"C Zen","year":"2011","unstructured":"Zen C, Zen Y, Mitry RR, Corbeil D, Karbanov\u00e1 J, O'Grady J, Karani J, Kane P, Heaton N, Portmann BC, Quaglia A (2011) Mixed phenotype hepatocellular carcinoma after transarterial chemoembolization and liver transplantation. Liver Transpl 17:943\u2013954. doi:\n10.1002\/lt.22314","journal-title":"Liver Transpl"},{"key":"2196_CR11","doi-asserted-by":"publisher","first-page":"1860","DOI":"10.1111\/j.1440-1746.2008.05601.x","volume":"23","author":"Y Nishihara","year":"2008","unstructured":"Nishihara Y, Aishima S, Kuroda Y, Iguchi T, Taguchi K, Asayama Y, Taketomi A, Kinukawa N, Honda H, Tsuneyoshi M (2008) Biliary phenotype of hepatocellular carcinoma after preoperative transcatheter arterial chemoembolization. J Gastroenterol Hepatol 23:1860\u20131868. doi:\n10.1111\/j.1440-1746.2008.05601.x","journal-title":"J Gastroenterol Hepatol"},{"key":"2196_CR12","doi-asserted-by":"publisher","first-page":"378","DOI":"10.1056\/NEJMoa0708857","volume":"359","author":"JM Llovet","year":"2008","unstructured":"Llovet JM, Ricci S, Mazzaferro V, Hilgard P, Gane E, Blanc J-F, de Oliveira AC, Santoro A, Raoul J-L, Forner A, Schwartz M, Porta C, Zeuzem S, Bolondi L, Greten TF, Galle PR, Seitz J-F, Borbath I, H\u00e4ussinger D, Giannaris T, Shan M, Moscovici M, Voliotis D, Bruix J, SHARP Investigators Study Group (2008) Sorafenib in advanced hepatocellular carcinoma. N Engl J Med 359:378\u2013390. doi:\n10.1056\/NEJMoa0708857","journal-title":"N Engl J Med"},{"key":"2196_CR13","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1093\/annonc\/mdt540","volume":"25","author":"JW Valle","year":"2014","unstructured":"Valle JW, Furuse J, Jitlal M, Beare S, Mizuno N, Wasan H, Bridgewater J, Okusaka T (2014) Cisplatin and gemcitabine for advanced biliary tract cancer: a meta-analysis of two randomised trials. Ann Oncol 25:391\u2013398. doi:\n10.1093\/annonc\/mdt540","journal-title":"Ann Oncol"},{"key":"2196_CR14","doi-asserted-by":"publisher","first-page":"183","DOI":"10.3350\/cmh.2015.21.2.183","volume":"21","author":"W Jung","year":"2015","unstructured":"Jung W, Kim B-H (2015) Cholangiolocellular carcinoma with satellite nodules showing intermediate differentiation. Clin Mol Hepatol 21:183\u2013186. doi:\n10.3350\/cmh.2015.21.2.183","journal-title":"Clin Mol Hepatol"},{"key":"2196_CR15","doi-asserted-by":"publisher","first-page":"1024","DOI":"10.1111\/liv.12563","volume":"35","author":"M Sasaki","year":"2015","unstructured":"Sasaki M, Sato H, Kakuda Y, Sato Y, Choi JH, Nakanuma Y (2015) Clinicopathological significance of \u201csubtypes with stem-cell feature\u201d in combined hepatocellular-cholangiocarcinoma. Liver Int 35:1024\u20131035. doi:\n10.1111\/liv.12563","journal-title":"Liver Int"},{"key":"2196_CR16","unstructured":"The Royal College of Pathologists (2012) Standards and datasets for reporting cancers Dataset for histopathology reporting of liver resection specimens (including gall bladder) and liver biopsies for primary and metastatic carcinoma (2nd edition). 1\u201351"},{"key":"2196_CR17","doi-asserted-by":"publisher","first-page":"4019","DOI":"10.3748\/wjg.v13.i29.4019","volume":"13","author":"G Senes","year":"2007","unstructured":"Senes G, Fanni D, Cois A, Uccheddu A, Faa G (2007) Intratumoral sampling variability in hepatocellular carcinoma: a case report. World J Gastroenterol 13:4019\u20134021. doi:\n10.3748\/wjg.v13.i29.4019","journal-title":"World J Gastroenterol"},{"key":"2196_CR18","doi-asserted-by":"publisher","first-page":"1592","DOI":"10.1136\/gut.2008.149062","volume":"57","author":"MA Silva","year":"2008","unstructured":"Silva MA, Hegab B, Hyde C, Guo B, Buckels JAC, Mirza DF (2008) Needle track seeding following biopsy of liver lesions in the diagnosis of hepatocellular cancer: a systematic review and meta-analysis. Gut 57:1592\u20131596. doi:\n10.1136\/gut.2008.149062","journal-title":"Gut"},{"key":"2196_CR19","doi-asserted-by":"publisher","first-page":"838949","DOI":"10.1155\/2014\/838949","volume":"2014","author":"AT Hauch","year":"2014","unstructured":"Hauch AT, Buell JF, McGowan M, Bhatia P, Lewin E, Killackey M, Shores NJ, Balart LA, Moehlen M, Saggi B, Paramesh AS (2014) Cutaneous metastases from primary hepatobiliary tumors as the first sign of tumor recurrence following liver transplantation. Case Rep Transplant 2014:838949\u2013838945. doi:\n10.1155\/2014\/838949","journal-title":"Case Rep Transplant"},{"key":"2196_CR20","doi-asserted-by":"publisher","first-page":"1951","DOI":"10.1158\/1078-0432.CCR-14-0122","volume":"21","author":"J Friemel","year":"2015","unstructured":"Friemel J, Rechsteiner M, Frick L, B\u00f6hm F, Struckmann K, Egger M, Moch H, Heikenwalder M, Weber A (2015) Intratumor heterogeneity in hepatocellular carcinoma. Clin Cancer Res 21:1951\u20131961. doi:\n10.1158\/1078-0432.CCR-14-0122","journal-title":"Clin Cancer Res"},{"key":"2196_CR21","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1038\/nrc3261","volume":"12","author":"A Marusyk","year":"2012","unstructured":"Marusyk A, Almendro V, Polyak K (2012) Intra-tumour heterogeneity: a looking glass for cancer? Nat Rev Cancer 12:323\u2013334. doi:\n10.1038\/nrc3261","journal-title":"Nat Rev Cancer"},{"key":"2196_CR22","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1007\/s00428-016-1987-9","volume":"469","author":"G Stanta","year":"2016","unstructured":"Stanta G, Jahn SW, Bonin S, Hoefler G (2016) Tumour heterogeneity: principles and practical consequences. Virchows Arch 469:371\u2013384. doi:\n10.1007\/s00428-016-1987-9","journal-title":"Virchows Arch"},{"key":"2196_CR23","doi-asserted-by":"publisher","first-page":"410","DOI":"10.1309\/AJCP8DMPEIMVH6YP","volume":"140","author":"Z Pan","year":"2013","unstructured":"Pan Z, Grizzle W, Hameed O (2013) Significant variation of immunohistochemical marker expression in paired primary and metastatic clear cell renal cell carcinomas. Am J Clin Pathol 140:410\u2013418. doi:\n10.1309\/AJCP8DMPEIMVH6YP","journal-title":"Am J Clin Pathol"},{"key":"2196_CR24","doi-asserted-by":"publisher","first-page":"883","DOI":"10.1056\/NEJMoa1113205","volume":"366","author":"M Gerlinger","year":"2012","unstructured":"Gerlinger M, Rowan AJ, Horswell S, Larkin J, Endesfelder D, Gronroos E, Martinez P, Matthews N, Stewart A, Tarpey P, Varela I, Phillimore B, Begum S, McDonald NQ, Butler A, Jones D, Raine K, Latimer C, Santos CR, Nohadani M, Eklund AC, Spencer-Dene B, Clark G, Pickering L, Stamp G, Gore M, Szallasi Z, Downward J, Futreal PA, Swanton C (2012) Intratumor heterogeneity and branched evolution revealed by multiregion sequencing. N Engl J Med 366:883\u2013892. doi:\n10.1056\/NEJMoa1113205","journal-title":"N Engl J Med"},{"key":"2196_CR25","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1126\/science.1239947","volume":"343","author":"BE Johnson","year":"2014","unstructured":"Johnson BE, Mazor T, Hong C, Barnes M, Aihara K, McLean CY, Fouse SD, Yamamoto S, Ueda H, Tatsuno K, Asthana S, Jalbert LE, Nelson SJ, Bollen AW, Gustafson WC, Charron E, Weiss WA, Smirnov IV, Song JS, Olshen AB, Cha S, Zhao Y, Moore RA, Mungall AJ, Jones SJM, Hirst M, Marra MA, Saito N, Aburatani H, Mukasa A, Berger MS, Chang SM, Taylor BS, Costello JF (2014) Mutational analysis reveals the origin and therapy-driven evolution of recurrent glioma. Science 343:189\u2013193. doi:\n10.1126\/science.1239947","journal-title":"Science"},{"key":"2196_CR26","doi-asserted-by":"publisher","first-page":"342","DOI":"10.1111\/j.1365-2559.2011.03902.x","volume":"59","author":"SW Jahn","year":"2011","unstructured":"Jahn SW, Winter G, Stacher E, Halbwedl I, Gattenl\u00f6hner S, Stockinger R, Spreitzer S, Waldispuehl-Geigl J, Geigl JB, Offner F, Hoefler G (2011) Multiple intratumoral KRAS mutations can clonally segregate to different lymph node metastases in colon cancer. Histopathology 59:342\u2013345. doi:\n10.1111\/j.1365-2559.2011.03902.x","journal-title":"Histopathology"},{"key":"2196_CR27","doi-asserted-by":"publisher","first-page":"696","DOI":"10.1093\/annonc\/mdn679","volume":"20","author":"C-H Gow","year":"2009","unstructured":"Gow C-H, Chang Y-L, Hsu Y-C, Tsai M-F, Wu C-T, Yu C-J, Yang C-H, Lee Y-C, Yang P-C, Shih J-Y (2009) Comparison of epidermal growth factor receptor mutations between primary and corresponding metastatic tumors in tyrosine kinase inhibitor-naive non-small-cell lung cancer. Ann Oncol 20:696\u2013702. doi:\n10.1093\/annonc\/mdn679","journal-title":"Ann Oncol"},{"key":"2196_CR28","doi-asserted-by":"publisher","first-page":"1429","DOI":"10.1097\/PAS.0b013e31817f1816","volume":"32","author":"LH Tang","year":"2008","unstructured":"Tang LH, Shia J, Soslow RA, Dhall D, Wong WD, O'Reilly E, Qin J, Paty P, Weiser MR, Guillem J, Temple L, Sobin LH, Klimstra DS (2008) Pathologic classification and clinical behavior of the spectrum of goblet cell carcinoid tumors of the appendix. Am J Surg Pathol 32:1429\u20131443. doi:\n10.1097\/PAS.0b013e31817f1816","journal-title":"Am J Surg Pathol"},{"key":"2196_CR29","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1007\/s004280050049","volume":"430","author":"M Papotti","year":"1997","unstructured":"Papotti M, Negro F, Carney JA, Bussolati G, Lloyd RV (1997) Mixed medullary-follicular carcinoma of the thyroid. A morphological, immunohistochemical and in situ hybridization analysis of 11 cases. Virchows Arch 430:397\u2013405","journal-title":"Virchows Arch"},{"key":"2196_CR30","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1186\/1471-2490-13-9","volume":"13","author":"N Zeh","year":"2013","unstructured":"Zeh N, Wild PJ, Bode PK, Kristiansen G, Moch H, Sulser T, Hermanns T (2013) Retroperitoneal teratoma with somatic malignant transformation: a papillary renal cell carcinoma in a testicular germ cell tumour metastasis following platinum-based chemotherapy. BMC Urol 13:9. doi:\n10.1186\/1471-2490-13-9","journal-title":"BMC Urol"},{"key":"2196_CR31","doi-asserted-by":"crossref","first-page":"1144","DOI":"10.1016\/S0022-5347(17)32524-7","volume":"152","author":"JS Little","year":"1994","unstructured":"Little JS, Foster RS, Ulbright TM, Donohue JP (1994) Unusual neoplasms detected in testis cancer patients undergoing post-chemotherapy retroperitoneal lymphadenectomy. J Urol 152:1144\u20131149","journal-title":"J Urol"},{"key":"2196_CR32","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1097\/PPO.0000000000000135","volume":"21","author":"A Afghahi","year":"2015","unstructured":"Afghahi A, Sledge GW (2015) Targeted therapy for cancer in the genomic era. Cancer J 21:294\u2013298. doi:\n10.1097\/PPO.0000000000000135","journal-title":"Cancer J"},{"key":"2196_CR33","doi-asserted-by":"publisher","first-page":"694","DOI":"10.1038\/ng.2256","volume":"44","author":"C Guichard","year":"2012","unstructured":"Guichard C, Amaddeo G, Imbeaud S, Ladeiro Y, Pelletier L, Maad IB, Calderaro J, Bioulac-Sage P, Letexier M, Degos F, Cl\u00e9ment B, Balabaud C, Chevet E, Laurent A, Couchy G, Letouz\u00e9 E, Calvo F, Zucman-Rossi J (2012) Integrated analysis of somatic mutations and focal copy-number changes identifies key genes and pathways in hepatocellular carcinoma. Nat Genet 44:694\u2013698. doi:\n10.1038\/ng.2256","journal-title":"Nat Genet"},{"key":"2196_CR34","doi-asserted-by":"publisher","first-page":"1470","DOI":"10.1038\/ng.2813","volume":"45","author":"Y Jiao","year":"2013","unstructured":"Jiao Y, Pawlik TM, Anders RA, Selaru FM, Streppel MM, Lucas DJ, Niknafs N, Guthrie VB, Maitra A, Argani P, Offerhaus GJA, Roa JC, Roberts LR, Gores GJ, Popescu I, Alexandrescu ST, Dima S, Fassan M, Simbolo M, Mafficini A, Capelli P, Lawlor RT, Ruzzenente A, Guglielmi A, Tortora G, de Braud F, Scarpa A, Jarnagin W, Klimstra D, Karchin R, Velculescu VE, Hruban RH, Vogelstein B, Kinzler KW, Papadopoulos N, Wood LD (2013) Exome sequencing identifies frequent inactivating mutations in BAP1, ARID1A and PBRM1 in intrahepatic cholangiocarcinomas. Nat Genet 45:1470\u20131473. doi:\n10.1038\/ng.2813","journal-title":"Nat Genet"},{"key":"2196_CR35","doi-asserted-by":"publisher","first-page":"1011","DOI":"10.1053\/hupa.2000.9782","volume":"31","author":"H Fujii","year":"2000","unstructured":"Fujii H, Zhu XG, Matsumoto T, Inagaki M, Tokusashi Y, Miyokawa N, Fukusato T, Uekusa T, Takagaki T, Kadowaki N, Shirai T (2000) Genetic classification of combined hepatocellular-cholangiocarcinoma. Hum Pathol 31:1011\u20131017. doi:\n10.1053\/hupa.2000.9782","journal-title":"Hum Pathol"},{"key":"2196_CR36","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1016\/j.jhep.2004.04.030","volume":"41","author":"D Cazals-Hatem","year":"2004","unstructured":"Cazals-Hatem D, Rebouissou S, Bioulac-Sage P, Bluteau O, Blanch\u00e9 H, Franco D, Monges G, Belghiti J, Sa Cunha A, Laurent-Puig P, Degott C, Zucman-Rossi J (2004) Clinical and molecular analysis of combined hepatocellular-cholangiocarcinomas. J Hepatol 41:292\u2013298. doi:\n10.1016\/j.jhep.2004.04.030","journal-title":"J Hepatol"}],"container-title":["Virchows Archiv"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00428-017-2196-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00428-017-2196-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00428-017-2196-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,11,2]],"date-time":"2017-11-02T05:31:29Z","timestamp":1509600689000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00428-017-2196-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,7,13]]},"references-count":36,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2017,11]]}},"alternative-id":["2196"],"URL":"https:\/\/doi.org\/10.1007\/s00428-017-2196-x","relation":{},"ISSN":["0945-6317","1432-2307"],"issn-type":[{"value":"0945-6317","type":"print"},{"value":"1432-2307","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,7,13]]}}}